Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation Fellows 2021

The Structural Heart Revolution: How it Started During My Fellowship and How Far It’s Come

Presenter: Susheel Kodali

May 09, 2021

News Daily News

Survey: Interventional Fellows Fear Missing Competency Goals Due to COVID-19

Yael L. Maxwell

May 22, 2020

Presentation TCT 2017

Editorial Perspective: Vascular Access Complications in the TAVR Area: Frequency and Clinical Outcomes

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Susheel K. Kodali

October 31, 2017

Presentation TVT 2016

The Sentinel US Pivotal Clinical Trial Design

Presenter: Susheel Kodali

June 17, 2016

Presentation TVT 2016

The Case for and Against Cerebral Embolic Protection During TAVR

Presenter: Susheel Kodali

June 16, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Daily News

第 12 个月时女性的经导管主动脉瓣结局优于男性

Shelley Wood

February 23, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Daily News

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Shelley Wood

February 23, 2016

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Paul Fefer

September 16, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Georgios C Bompotis

September 16, 2014

Presentation TCT 2014

Case #3: Left Main Intervention in ACS

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Paul Fefer

September 16, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Advertisement

The Structural Heart Revolution: How it Started During My Fellowship and How Far It’s Come

Survey: Interventional Fellows Fear Missing Competency Goals Due to COVID-19

Editorial Perspective: Vascular Access Complications in the TAVR Area: Frequency and Clinical Outcomes

The Sentinel US Pivotal Clinical Trial Design

The Case for and Against Cerebral Embolic Protection During TAVR

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

第 12 个月时女性的经导管主动脉瓣结局优于男性

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #3: Left Main Intervention in ACS

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content